Term Name: | beta-L-IdopA2S-(1->3)-beta-D-GalpNAc4S-(1->4)-beta-D-GlcpA-(1->3)-beta-D-GalpNAc4S |
---|---|
Synonyms: | (2-O-sulfo-beta-L-idopyranosyluronic acid)-(1->3)-2-acetamido-2-deoxy-4-O-sulfo-beta-D-galactopyranosyl-(1->4)-(beta-D-glucopyranosyluronic acid)-(1->3)-2-acetamido-2-deoxy-4-O-sulfo-D-galactopyranose, 2-O-sulfo-beta-L-idopyranuronosyl-(1->3)-2-acetamido-2-deoxy-4-O-sulfo-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->3)-2-acetamido-2-deoxy-4-O-sulfo-D-galactopyranose, beta-L-IdoA2S-(1->3)-beta-D-GalNAc4S-(1->4)-beta-D-GlcA-(1->3)-beta-D-GalNAc4S, IdoA(S)-GalNAc(S)-GlcA-GalNAc(S) |
Definition: | An amino tetrasaccharide comprised of an L-iduronic acid residue, sulfated on O-2, a glucuronic acid residue, and two N-acetylated galactosamine residues, one of which is at the reducing end and both of which are sulfated on O-4. It is an intermediate in the chondroitin sulfate degradation pathway. |
Ontology: | ChEBI [CHEBI:63854] ( EBI ) |